news
WuXi Biologics partners with HanchorBio on next-gen immunotherapies
The CRDMO will support the biotech company’s work on next-generation immunotherapies for oncology and autoimmune diseases.
List view / Grid view
Contract Manufacturing
article
Gaelic Labs: Pharma is increasingly focused on supply chain security
General Manager Brian Morrissey discuss his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
news
Kincell Bio promotes Bruce Thompson to President and Chief Technology Officer
The cell therapy-focused CDMO has also elevated Melodie Bryce to Chief Quality Officer and Matt Haines to Chief Operations Officer.
article
ReiThera on vaccines and remaining nimble around emerging threats
As vaccines are buffeted by political pressures, the CDMO discussed its growth approach and some of its key collaborations.
article
Fujifilm’s Lars Petersen on trust-based partnerships and a ‘people first’ culture
Named CEO of the Year at CPHI Frankfurt, the CDMO's head talks about the type of company he and his team are building.
news
Samsung gains first US manufacturing site through $280m GSK deal
The CDMO will acquire the pharma company’s Human Genome Sciences facility in Maryland.
news
Gaelic Labs boosts its beta lactam manufacturing with Athlone deal
The move consolidates Ireland’s two leading producers of the antibiotics.
article
A careful calibration: balancing small molecule needs and biologic innovation
CDMOs weigh up how to meet manufacturing demands across oral solid doses, monoclonal antibodies, ADCs and beyond.
article
European Pharmaceutical Review Issue 4 2025
EPR Issue 4 includes articles on manufacturing, AI/ML, vaccine development, biologics and more.
news
Novel NMR-based method could facilitate safer API manufacturing
The innovative approach for detecting nitrosamine impurities in APIs addresses limitations of traditional mass-based techniques, research says.
news
CRDMO BioDuro appoints Yaohui Ji as global president for CMC
He joins from contract development and manufacturing organisation Porton Pharma Solutions.
news
Hovione doubles spray drying capacity with $100m US investment round
The CDMO’s New Jersey manufacturing site expansion will eventually cover more than 200,000 square feet.
news
CPHI Europe adds AI and tech zone for its return to Milan in 2026
Following 2025’s event in Frankfurt, Informa’s flagship pharma exhibition will next year include an area for artificial intelligence.
news
Taiwan talks evidence-driven TCM at CPHI Frankfurt
Scientific and commercial opportunity for pharma companies looking to source, co develop and manufacture traditional Chinese medicine (TCM).
news
Axplora talks reliability-first investments to secure API supply
The CDMO’s programme, presented at CPHI Frankfurt 2025, combines responsiveness to new demand and operational rigour without jeopardising supply.
